http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—For people who have suffered from cellulitis of the leg, a long course of low-dose penicillin prevents the painful infection from returning, British researchers report. http://medicalxpress.com/news/2013-05-penicillin-leg-infection-cellulitis.html Diseases, Conditions, Syndromes Thu, 02 May 2013 05:50:03 EST news286690754 A new discovery about the malaria-related parasite Toxoplasma gondii—which can threaten babies, AIDS patients, the elderly and others with weakened immune function—may help solve the mystery of how this single-celled parasite establishes life-long infections in people. http://medicalxpress.com/news/2013-04-proteins-chronic-disease-toxoplasma-infections.html Medical research Mon, 08 Apr 2013 16:19:44 EST news284656765 In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Generally studies do this with billing or treatment codes – certain codes should identify who does and does not have recurrent cancer. A recent study published in the journal Medical Care shows that the commonly used data determinants of recurrent cancer may be misidentifying patients and potentially leading researchers astray. http://medicalxpress.com/news/2013-01-common-recurrent-cancer-broken.html Cancer Wed, 02 Jan 2013 14:18:59 EST news276358731 (HealthDay)—For women who have undergone a hysterectomy for endometrial cancer, abnormal Papanicolaou (Pap) test results do not aid in diagnosing recurrent disease, according to a study published in the January issue of Obstetrics & Gynecology. http://medicalxpress.com/news/2012-12-limited-pap-endometrial-cancer-recurrence.html Obstetrics & gynaecology Fri, 28 Dec 2012 15:00:01 EST news275927506 A study of more than 33,000 outpatient male veterans suggests that a longer duration of antimicrobial treatment of more than seven days for a urinary tract infection (UTI) appeared not to be associated with a reduced risk of early or late recurrence compared to a shorter duration (seven days or less) of treatment, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. http://medicalxpress.com/news/2012-12-longer-treatment-male-uti-early.html Diseases, Conditions, Syndromes Mon, 03 Dec 2012 16:00:20 EST news273758214 More than half of all patients with ovarian cancer experience recurrent disease and will eventually fail to respond to chemotherapy. The failure of chemotherapy is usually due to the development of resistance to the two main classes of chemotherapy agents used to fight it – platinating agents and taxanes. Now, a study reported in the open-access Journal of Ovarian Research provides novel information that further adds to clinicians' understanding of the mechanisms involved in the development of resistance to dual-agent chemotherapy. http://medicalxpress.com/news/2012-11-mechanisms-drug-resistance-dual-agent-chemotherapy.html Cancer Thu, 29 Nov 2012 19:00:01 EST news273434985 Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. http://medicalxpress.com/news/2012-09-denosumab-burden-giant-cell-tumor-bone.html Cancer Fri, 21 Sep 2012 11:41:14 EST news267446466 (HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete remission, according to the results of a phase II study published online May 21 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2012-05-brentuximab-vedotin-effective-large-cell-lymphoma.html Cancer Thu, 24 May 2012 18:00:01 EST news257100621 Patients who have high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study. Their study is the first to report on multiple patients with these skin carcinomas treated simultaneously with radio-and chemotherapy. http://medicalxpress.com/news/2011-10-combination-therapy-beneficial-neck-skin.html Cancer Tue, 04 Oct 2011 11:04:42 EST news236944966 Bevacizumab (Avastin) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer, according to a new study. Results from the phase III "OCEANS" trial were presented today by the lead author, Carol Aghajanian, MD, of Memorial Sloan-Kettering Cancer Center, at the 2011 annual meeting of the American Society of Clinical Oncology. http://medicalxpress.com/news/2011-06-drug-combination-tumor-growth-recurrent.html Cancer Mon, 06 Jun 2011 11:40:01 EST news226576145